![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Found 123 studies with search of: | "Anastrozole" |
Hide studies that are not seeking new volunteers.
|
|
1 | Active, not recruiting | Comparison of Anastrozole Verses Clomiphene Citrate in Stimulating Follicular Growth and Ovulation in Infertile Women With Ovulatory Dysfunction | ||||
Condition: | Anovulation | |||||
Interventions: | Drug: Anastrozole 1mg; Drug: Anastrozole 5mg dose; Drug: Anastrozole 10mg dose; Drug: Clomiphene Citrate 50mg | |||||
2 | Recruiting | Anastrozole Plus Lonafarnib (SCH 66336) or Plus Placebo for the Treatment of Advanced Breast Cancer (Study P03480AM5) | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Lonafarnib plus Anastrozole; Drug: Placebo plus Anastrozole | |||||
3 | Completed | Iressa (ZD1839) Plus Anastrozole (Arimidex) in Patients With Ovarian Cancer | ||||
Conditions: | Ovarian Cancer; Peritoneal Carcinoma; Tubal Carcinoma | |||||
Interventions: | Drug: Iressa (ZD1839); Drug: Arimidex (Anastrozole) | |||||
4 | Active, not recruiting | Anastrozole and Fulvestrant Compared to Anastrozole as Adjuvant Treatment of Postmenopausal Patients With Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Fulvestrant; Drug: Anastrozole | |||||
5 | Active, not recruiting | Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Fulvestrant; Drug: Anastrozole | |||||
6 | Recruiting | Arimidex With Or Without Faslodex In Postmenopausal Women With HR Positive Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Arimidex with Faslodex; Drug: Arimidex without Faslodex | |||||
7 | Completed | Gynecomastia Extension Study | ||||
Condition: | Gynecomastia | |||||
Intervention: | Drug: Anastrozole | |||||
8 | Recruiting | Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Tamoxifen; Drug: Anastrazole (Arimidex); Drug: Goserelin acetate (Zoladex) | |||||
9 | Recruiting | Liver Safety Under Upfront Arimidex vs Tamoxifen | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Anastrozole; Drug: Tamoxifen | |||||
10 | Completed | Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Anastrozole; Drug: Risedronate Sodium | |||||
11 | Active, not recruiting | Tamoxifen Versus Anastrozole, Alone or in Combination With Zoledronic Acid | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: tamoxifen; Drug: anastrozole; Drug: zoledronic acid | |||||
12 | Active, not recruiting | A Clinical Trial to Compare Efficacy and Tolerability of Faslodex With Arimidex in Patients With Advanced Breast Cancer | ||||
Condition: | Metastatic Breast Cancer | |||||
Interventions: | Drug: fulvestrant; Drug: anastrozole | |||||
13 | Active, not recruiting | Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis] | ||||
Condition: | Puberty, Precocious | |||||
Interventions: | Drug: Bicalutamide; Drug: Anastrozole | |||||
14 | Recruiting | Different Durations of Adjuvant Anastrozole Therapy After 2 to 3 Years Tamoxifen Therapy in Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Intervention: | Drug: Anastrozole | |||||
15 | Active, not recruiting | Effectiveness of Combination of Arimidex and Nolvadex in Adjuvant Therapy of Breast Carcinoma in Postmenopausal Women. | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Anastrozole; Drug: Tamoxifen | |||||
16 | Recruiting | Arthralgia During Anastrozole Therapy for Breast Cancer | ||||
Condition: | Early Breast Cancer | |||||
Intervention: | Drug: Anastrozole | |||||
17 | Recruiting | Bevacizumab Given With Either Anastrozole or Fulvestrant With Trastuzumab for Postmenopausal Metastatic Breast Cancer | ||||
Conditions: | Breast Cancer; Breast Neoplasms | |||||
Interventions: | Drug: Bevacizumab; Drug: Anastrozole; Drug: Fulvestrant | |||||
18 | Recruiting | Anti-Tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Fulvestrant; Drug: Anastrazole | |||||
19 | Completed | Faslodex Advanced Breast Cancer Local Chinese Study | ||||
Condition: | Advanced Breast Cancer | |||||
Interventions: | Drug: Fulvestrant; Drug: Anastrozole | |||||
20 | Active, not recruiting | ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Anastrozole; Drug: Tamoxifen | |||||
21 | Completed | Trial Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor (ER) and/or Progesterone Receptor (PgR) Metastatic Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Gefitinib; Drug: Anastrozole | |||||
22 | Completed | Ax-003/Arimidex (Anastrozole) in the Adjuvant Therapy of Early Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Intervention: | Drug: Anastrozole | |||||
23 | Recruiting | Pre-Operative Hormonal Treatment for Hormone Receptor Positive Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Anastrozole; Drug: Anastrozole+Fulvestrant; Drug: Tamoxifen; Drug: Tamoxifen | |||||
24 | Completed | Open Label Arimidex in Gynecomastia | ||||
Condition: | Gynecomastia | |||||
Intervention: | Drug: Anastrozole (ARIMIDEX™) | |||||
25 | Active, not recruiting | Arimidex Multicenter Trial in Growth Hormone (GH) Deficient Boys | ||||
Condition: | Hypopituitarism | |||||
Intervention: | Drug: Arimidex (Anastrozole) | |||||
26 | Recruiting | Aromasin vs Arimidex Study As Initial Hormonal Therapy in Postmenopausal Women With Advanced/Recurrent Breast Cancer | ||||
Condition: | Breast Neoplasms | |||||
Interventions: | Drug: anastrozole; Drug: exemestane | |||||
27 | Recruiting | Patient's Anastrozole Compliance to Therapy Programme | ||||
Condition: | Breast Cancer | |||||
Intervention: | Drug: Anastrozole | |||||
28 | Completed | Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Intervention: | Drug: Letrozole, anastrozole | |||||
29 | Completed | Second Line Breast Cancer Trial | ||||
Condition: | Advanced Breast Cancer | |||||
Interventions: | Drug: Fulvestrant; Drug: Anastrozole; Drug: Fulvestrant | |||||
30 | Recruiting | Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women With Clinical Stage II and III Estrogen Receptor Positive Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: exemestane; Drug: letrozole; Drug: anastrozole | |||||
31 | Recruiting | Anastrozole With or Without Fulvestrant as First-Line Therapy in Treating Postmenopausal Women With Metastatic Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: fulvestrant | |||||
32 | Completed | Anastrozole With or Without Lonafarnib in Treating Postmenopausal Women With Stage IIIB, Stage IIIC, or Stage IV Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: lonafarnib | |||||
33 | Active, not recruiting | Anastrozole With or Without Gefitinib in Treating Postmenopausal Women With Metastatic or Locally Recurrent Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: gefitinib | |||||
34 | Recruiting | Fulvestrant With or Without Anastrozole or Exemestane Alone in Treating Postmenopausal Women With Locally Advanced or Metastatic Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: exemestane; Drug: fulvestrant | |||||
35 | Recruiting | STARS Breast Trial (Study of Anastrozole and Radiotherapy Sequencing Pilot) | ||||
Condition: | Breast Cancer | |||||
Intervention: | Drug: Timing of Anastrozole in respect to radiotherapy | |||||
36 | Not yet recruiting | CEP-1 Hormonal Regulation of Circulating Endothelial Progenitor Cells | ||||
Condition: | Healthy | |||||
Interventions: | Drug: Acyline; Drug: Acyline + Testosterone gel; Drug: Acyline + testosterone gel + anastrozole | |||||
37 | Active, not recruiting | Anastrozole Administration in Elderly Hypogonadal Men | ||||
Condition: | Hypogonadism | |||||
Intervention: | Drug: anastrozole | |||||
38 | Recruiting | Simvastatin and Anastrozole in Treating Postmenopausal Women With Invasive Breast Cancer, Ductal Carcinoma In Situ, or a High Risk of Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: simvastatin; Procedure: adjuvant therapy; Procedure: pharmacological study | |||||
39 | Recruiting | Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Intervention: | Drug: anastrozole | |||||
40 | Recruiting | Chemoprevention Trial - Anastrozole in DCIS in Postmenopausal Women | ||||
Conditions: | DCIS; Early Invasive Breast Cancer | |||||
Intervention: | Drug: Anastrozole | |||||
41 | Active, not recruiting | Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: tamoxifen citrate; Procedure: adjuvant therapy; Procedure: radiation therapy | |||||
42 | Active, not recruiting | Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Ductal Carcinoma in Situ or Stage I, Stage II, or Stage III Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Procedure: adjuvant therapy | |||||
43 | Active, not recruiting | Exemestane or Anastrozole in Treating Postmenopausal Women With Hormone Receptor-Positive Primary Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: exemestane; Procedure: adjuvant therapy | |||||
44 | Active, not recruiting | Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: exemestane; Procedure: adjuvant therapy | |||||
45 | Recruiting | Sorafenib and Anastrozole in Treating Postmenopausal Women With Metastatic Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: sorafenib tosylate | |||||
46 | Completed | Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: goserelin | |||||
47 | Recruiting | Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: tamoxifen citrate; Procedure: adjuvant therapy | |||||
48 | Recruiting | Anastrozole or Fulvestrant in Treating Postmenopausal Women With Stage II or Stage III Breast Cancer That Can Be Removed By Surgery | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: anastrozole; Drug: fulvestrant; Procedure: adjuvant therapy; Procedure: neoadjuvant therapy; Procedure: radiation therapy; Procedure: therapeutic conventional surgery | |||||
49 | Completed | A Prospective,Open-Label Study of Anastrozole in Post-Menopausal Women With Hormone Sensitive Advanced Breast Cancer | ||||
Condition: | Breast Cancer | |||||
Intervention: | Drug: Anastrozole | |||||
50 | Active, not recruiting | Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients | ||||
Condition: | Breast Cancer | |||||
Interventions: | Drug: Exemestane; Drug: Anastrozole | |||||
Studies Shown (1-50) | Next (51-100) | ![]() |
![]() |